The Valley Desk

Clinical trial reportEpilepsiaPublished

A randomized, double-blind, placebo-controlled, time-to-event study of the efficacy and safety of JNJ-40411813 in combination with levetiracetam or brivaracetam in patients with focal onset seizures

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Epilepsia
Published
Subject terms
Humans; Epilepsies, Partial; Seizures; Pyrrolidinones; Anticonvulsants; Treatment Outcome; Drug Therapy, Combination; Double-Blind Method; Adolescent; Adult; Middle Aged; Female
PubMed ID
41175011
Added to directory
Source checked

Report a correction or request removal